These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36812272)

  • 1. Dystrophic Epidermolysis Bullosa Inversa - Case Report and Review of the Literature.
    Merzel Šabović EK; Luzar B; Wechtersbach K; Dolenc-Voljč M
    Acta Dermatovenerol Croat; 2022 Nov; 30(3):151-156. PubMed ID: 36812272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophic epidermolysis bullosa inversa: report of two cases with further correlation between electron microscopic and immunofluorescence studies.
    Lin AN; Smith LT; Fine JD
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 2):361-5. PubMed ID: 7615886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophic epidermolysis bullosa inversa: a case report.
    Altomare GF; Polenghi M; Pigatto PD; Nazzaro V; Piattoni F
    Dermatologica; 1990; 181(2):145-8. PubMed ID: 2173667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A.
    Liu J; Wang L
    Acta Dermatovenerol Croat; 2021 Dec; 29(3):164-166. PubMed ID: 34990346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic Epidermolysis Bullosa.
    Yadav RS; Jayswal A; Shrestha S; Gupta SK; Paudel U
    JNMA J Nepal Med Assoc; 2018; 56(213):879-882. PubMed ID: 31065125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Localised de novo dominant dystrophic epidermolysis bullosa].
    Bursztejn AC; Pinault AL; Le Louarn Y; Lacour JP; Charlesworth A; Meneguzzi G; Truchetet F
    Ann Dermatol Venereol; 2008 Mar; 135(3):195-9. PubMed ID: 18374850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII.
    Leverkus M; Ambach A; Hoefeld-Fegeler M; Kohlhase J; Schmidt E; Schumann H; Has C; Gollnick H
    Br J Dermatol; 2011 May; 164(5):1104-6. PubMed ID: 21275939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Syndromes 13. Epidermolysis bullosa].
    Meijndert L; Jonkman MF
    Ned Tijdschr Tandheelkd; 1999 Aug; 106(8):302-5. PubMed ID: 11930425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recessive Dystrophic Epidermolysis Bullosa and Pregnancy.
    Boria F; Maseda R; Martín-Cameán M; De la Calle M; de Lucas R
    Actas Dermosifiliogr (Engl Ed); 2019; 110(1):50-52. PubMed ID: 29203033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and etiology of childhood epidermolysis bullosa mortality.
    Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
    J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited epidermolysis bullosa: update on the clinical and genetic aspects.
    Mariath LM; Santin JT; Schuler-Faccini L; Kiszewski AE
    An Bras Dermatol; 2020; 95(5):551-569. PubMed ID: 32732072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal hereditary dystrophic epidermolysis bullosa: a genetically diagnosed case report].
    Jiang Y; Hou XL; Li X; Lin ZS; Cui C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):202-6. PubMed ID: 23591337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis Bullosa Pruriginosa: Case Series and Review of the Literature.
    Kim WB; Alavi A; Pope E; Walsh S
    Int J Low Extrem Wounds; 2015 Jun; 14(2):196-9. PubMed ID: 25694436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
    Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
    J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic dystrophic epidermolysis bullosa with concomitant atopic dermatitis.
    Lapinski P; Lapiere JC; Traczyk T; Chan LS
    Br J Dermatol; 1998 Feb; 138(2):315-20. PubMed ID: 9602882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.
    Nyström A; Buttgereit J; Bader M; Shmidt T; Ozcelik C; Hausser I; Bruckner-Tuderman L; Kern JS
    PLoS One; 2013; 8(5):e64243. PubMed ID: 23717576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant dystrophic epidermolysis bullosa with congenital absence of skin and brachydactyly of the great toes.
    Sawka E; Funk T
    Pediatr Dermatol; 2021 Sep; 38(5):1251-1254. PubMed ID: 34338359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and transmission electron microscopy of generalized dystrophic epidermolysis bullosa (Pasini's albopapuloid subtype).
    Almeida HL; Nudelmann L; Rocha NM; Castro LA
    An Bras Dermatol; 2012; 87(2):285-7. PubMed ID: 22570034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.
    McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA
    J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.